GGrantIndex
Sort

85,873 grants matching alzheimers

Core C: Clinical Core

$5,290,290
Benjamin L Handen · University Of Pittsburgh At Pittsburgh · U19 · FY2021 · AG

National Cell Repository for Alzheimer's Disease (NCRAD)

$5,285,662
Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2019 · AG

EFFECTS OF TRAUMATIC BRAIN INJURY AND POST TRAUMATIC STRESS DISORDER AND ALZHEIMER'S DISEASE ON BRAIN TAU IN VIETNAM VETERANS USING ADNI

$5,281,404
Northern California Institute For Research And Education, Inc. · · FY2014 · Department of the Army

A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease

$5,279,327
Howard Feldman · University Of California, San Diego · R01 · FY2019 · AG

Improving causal inference in Alzheimer's Disease prevention research on modifiable risk factors: the Triangulation of Innovative Methods to EndAD (TIME-AD) project

$5,262,301
Medellena Maria Glymour · Boston University Medical Campus · P01 · FY2024 · AG

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial

$5,258,914
Randall J Bateman · Washington University · R01 · FY2017 · AG

Core C: Clinical Core

$5,250,122
Benjamin L Handen · University Of Pittsburgh At Pittsburgh · U19 · FY2025 · AG

Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia

$5,244,895
Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2020 · AG

The role of the renin-angiotensin-endothelial pathway in AD

$5,234,913
Ihab M Hajjar · Emory University · RF1 · FY2015 · AG

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial

$5,232,530
Randall J Bateman · Washington University · R01 · FY2016 · AG

Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial

$5,232,087
Randall J Bateman · Washington University · R01 · FY2018 · AG

The Origins of Alzheimer Disease in African Americans

$5,228,081
Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2024 · AG

Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old

$5,224,302
Rachel A Whitmer · University Of California At Davis · R01 · FY2024 · AG

Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3

$5,219,447
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES

The Origins of Alzheimer Disease in African Americans

$5,208,535
Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2023 · AG

Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort

$5,205,689
Marilyn S Albert · Johns Hopkins University · U19 · FY2020 · AG

National Cell Repository for Alzheimer's Disease (NCRAD)

$5,205,087
Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2020 · AG

Additional Sequencing for the Alzheimer's Disease Sequencing Project (ADSP)

$5,202,937
Jeffery M. Vance · University Of Miami School Of Medicine · U01 · FY2022 · AG

Systems Genetic Analysis of Cognitive Resilience Using Multi-Parent Crosses

$5,201,511
Catherine Cook Kaczorowski · Jackson Laboratory · RF1 · FY2019 · AG

PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE

$5,188,211
University Of Washington · U01 · FY2002 · AG

Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old

$5,187,231
Rachel A Whitmer · University Of California At Davis · R01 · FY2023 · AG

General Clinical Research Center

$5,182,258
Paul Ramsey · University Of Washington · M01 · FY2006 · RR

Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis

$5,175,354
Randall J Bateman · Washington University · R01 · FY2024 · AG

Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy Bodies

$5,174,076
Ashkan Vaziri · Biosensics, Llc · UF1 · FY2025 · AG

The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)

$5,172,719
Amy J. Kind · University Of Wisconsin-Madison · R01 · FY2025 · AG